COVID-19 Archives
AstraZeneca VP to discuss COVID-19 collaboration with VUMC Nov. 17
Nov. 10, 2022—On Thursday, Nov. 17, Mark Esser, PhD, vice president, Early Vaccines and Immune Therapies R&D at AstraZeneca, will discuss his company’s collaboration with Vanderbilt University Medical Center that led to development of the Evusheld antibody combo to prevent COVID-19 in high-risk individuals.
CDC health care worker COVID-19 vaccine effectiveness study underway
Nov. 8, 2022—VUMC’s department of Health Policy, in conjunction with the Centers for Disease Control and Prevention (CDC), is working with health care workers to determine the effectiveness of the COVID-19 vaccine in the health care workplace. Emails with a link to a survey will be sent to those who are tested for COVID-19 (the email will...
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
Nov. 4, 2022—A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.
Event to spotlight VUMC’s COVID-19 research efforts
Nov. 3, 2022—The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall.
COVID-19 Guideline Revisions & Updates – Important updates to guidelines such as pre-procedure testing and clinical guidelines
Oct. 31, 2022—Several COVID-19 Guidelines have been updated. Here is a summary of the updates with links to revised guidelines on the COVID-19 website. Pre-Procedure Testing Changes: Effective Nov.14, VUMC guidelines for Pre-Procedure Testing will be updated to stop some requirements for preprocedural testing. Revised Guidelines can be found here. Exposure and Return to Work Updated Guidelines:...
Jahangir shares COVID lessons at Reunion Weekend
Oct. 13, 2022—by Bill Snyder As head of Metro Nashville’s COVID-19 Task Force during the height of the pandemic, Vanderbilt orthopaedic trauma surgeon Alex Jahangir, MD, MMHC, witnessed a wide swing of human emotions. Mask mandates, designed to curb the spread of the virus, were met with resistance and outright hostility. Yet many Nashvillians quietly went out...
Cardiologist Brown finds inspiration through music
Oct. 13, 2022—Vanderbilt's Suzanne Brown Sacks, MD, is both a transplant cardiologist and an accomplished singer/songwriter.
Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America
Oct. 6, 2022—Vanderbilt's James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization.
VUMC lands grant to build top-line biosafety facility
Sep. 29, 2022—Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.
Masking guidance updated — Masks no longer required in non-clinical areas
Sep. 23, 2022—Leaders across VUMC continue to monitor important metrics around COVID-19, including rates of transmission and severe infection, which have been steadily dropping. Most of the local counties served by VUMC are no longer in the “high” category for severe infections, as determined by the Centers for Disease Control and Prevention. Additionally, new bivalent COVID-19 booster...
PheWAS reveals post-COVID-19 diagnoses
Sep. 8, 2022—Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses.
Neurologic complications common in children hospitalized with COVID
Aug. 25, 2022—Vanderbilt researchers have found another reason to vaccinate children against COVID-19: to help reduce the likelihood of neurologic complications caused by the virus.
